| Jul 16 |
What Makes Insmed Incorporated (INSM) a Prospective Investment?
|
| Jul 14 |
Rivian Automotive & Baidu Are Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 7-July 13): Are The Others In Your Portfolio?
|
| Jul 3 |
Insmed sees brensocatib NDA for bronchiectasis in Q4
|
| Jul 3 |
More endpoints met in Insmed’s Phase III brensocatib trial
|
| Jul 3 |
Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week
|
| Jul 3 |
Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
|
| Jul 2 |
Pharma companies shape competitive pipeline for bronchiectasis
|
| Jun 27 |
Insmed redeems all $225 million of outstanding 1.75% convertible senior notes
|
| Jun 27 |
Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025
|
| Jun 14 |
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
|
